Bavari S - Search Results

1

Discovering Drugs for the Treatment of Ebola Virus.

Bixler SL, Duplantier AJ, Bavari S. Bixler SL, et al. Among authors: bavari s. Curr Treat Options Infect Dis. 2017;9(3):299-317. doi: 10.1007/s40506-017-0130-z. Epub 2017 Aug 4. Curr Treat Options Infect Dis. 2017. PMID: 28890666 Free PMC article. Review.

2

Ebola and Marburg viruses replicate in monocyte-derived dendritic cells without inducing the production of cytokines and full maturation.

Bosio CM, Aman MJ, Grogan C, Hogan R, Ruthel G, Negley D, Mohamadzadeh M, Bavari S, Schmaljohn A. Bosio CM, et al. Among authors: bavari s. J Infect Dis. 2003 Dec 1;188(11):1630-8. doi: 10.1086/379199. Epub 2003 Nov 14. J Infect Dis. 2003. PMID: 14639532

3

Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge.

Warfield KL, Swenson DL, Olinger GG, Kalina WV, Aman MJ, Bavari S. Warfield KL, et al. Among authors: bavari s. J Infect Dis. 2007 Nov 15;196 Suppl 2:S430-7. doi: 10.1086/520583. J Infect Dis. 2007. PMID: 17940980

4

Searching for Therapeutics Against Botulinum Neurotoxins: A True Challenge for Drug Discovery.

Duplantier AJ, Kane CD, Bavari S. Duplantier AJ, et al. Among authors: bavari s. Curr Top Med Chem. 2016;16(21):2330-49. doi: 10.2174/1568026616666160413135630. Curr Top Med Chem. 2016. PMID: 27072693 Review.

5

Ebola virus disease candidate vaccines under evaluation in clinical trials.

Martins KA, Jahrling PB, Bavari S, Kuhn JH. Martins KA, et al. Among authors: bavari s. Expert Rev Vaccines. 2016 Sep;15(9):1101-12. doi: 10.1080/14760584.2016.1187566. Epub 2016 May 27. Expert Rev Vaccines. 2016. PMID: 27160784 Free PMC article. Review.

6

Evaluation of Ebola Virus Inhibitors for Drug Repurposing.

Madrid PB, Panchal RG, Warren TK, Shurtleff AC, Endsley AN, Green CE, Kolokoltsov A, Davey R, Manger ID, Gilfillan L, Bavari S, Tanga MJ. Madrid PB, et al. Among authors: bavari s. ACS Infect Dis. 2015 Jul 10;1(7):317-26. doi: 10.1021/acsinfecdis.5b00030. Epub 2015 May 11. ACS Infect Dis. 2015. PMID: 27622822

7

Antiviral therapeutics for the treatment of Ebola virus infection.

Cardile AP, Downey LG, Wiseman PD, Warren TK, Bavari S. Cardile AP, et al. Among authors: bavari s. Curr Opin Pharmacol. 2016 Oct;30:138-143. doi: 10.1016/j.coph.2016.08.016. Curr Opin Pharmacol. 2016. PMID: 27639220 Review.

8

Will There Be a Cure for Ebola?

Cardile AP, Warren TK, Martins KA, Reisler RB, Bavari S. Cardile AP, et al. Among authors: bavari s. Annu Rev Pharmacol Toxicol. 2017 Jan 6;57:329-348. doi: 10.1146/annurev-pharmtox-010716-105055. Epub 2016 Dec 7. Annu Rev Pharmacol Toxicol. 2017. PMID: 27959624 Review.

9

Asymptomatic Ebola virus infections-myth or reality?

Kuhn JH, Bavari S. Kuhn JH, et al. Among authors: bavari s. Lancet Infect Dis. 2017 Jun;17(6):570-571. doi: 10.1016/S1473-3099(17)30110-X. Epub 2017 Feb 28. Lancet Infect Dis. 2017. PMID: 28256309 Free article. No abstract available.

10

Clinical Laboratory Values in Human Ebola Virus Disease Support the Relevance of the Intramuscular Ebola-Kikwit Rhesus Model.

Reisler RB, Kraft CS, Bavari S, Cardile AP. Reisler RB, et al. Among authors: bavari s. Clin Infect Dis. 2018 Apr 17;66(9):1479-1480. doi: 10.1093/cid/cix1025. Clin Infect Dis. 2018. PMID: 29272400 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

322 results

Search Page